Medical technology group EMVision Medical Devices (ASX: EMV) has begun clinical trials of its novel stroke detection instrument (pictured).
The company announced that it had received the green light for trials which have now begun at the Princess Alexandra Hospital in Brisbane.
EMVision CEO Ron Weinberger said: “Taking a prototype of our complexity from the lab to a device that is designed for and meets the needs of a clinical trial in 12 months is a significant feat.
“As we commence our pilot clinical trial, we embark on a major step forward for the diagnosis and monitoring of stroke at the point of care.”
The EMVision device uses electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications.
It features an optimised antenna array, innovative signal processing algorithms, and machine learning technology for stroke classification.
The technology is the result of research let by Professor Amin Abbosh and Professor Stuart Crozier at the University of Queensland.
Subscribe to our free @AuManufacturing newsletter here.